台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    63.6
  • 漲跌
    ▼3.1
  • 漲幅
    -4.65%
  • 成交量
    103
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-永豐金-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/0800.001.567.5968.90-1.5251-0.61%
2024/03/1200.00260.1059.90-2222-0.90%
2024/03/1100.00162.0061.40-1218-0.46%
2024/03/08162.80260.8061.00-1214-0.47%
2024/03/0100.000.154.4054.80-0.1183-0.05%
2024/02/2600.00152.1052.10-1181-0.55%
2024/02/2300.00153.5052.20-1182-0.55%
2024/02/20352.2000.0048.3031801.66%
2024/02/15355.40153.0055.5021771.12%
2024/01/31243.0000.0045.6021491.33%
2024/01/0200.001040.9640.80-10240-4.16%
2023/12/14138.9000.0038.9512230.45%
2023/12/11139.5000.0039.0012200.45%
2023/12/07240.7000.0040.5022130.94%
2023/11/1300.001634.6034.20-16154-10.35%
2023/08/29221.8500.0021.502712.78%
2023/08/25221.7000.0021.702732.72%
2023/08/24221.9500.0021.952732.71%
2023/08/23421.9000.0022.004735.41%
2023/06/28722.851623.0023.00-990-9.96%
2023/06/21121.6000.0021.901991.01%
2023/06/20221.4000.0021.5521021.95%
2023/03/171620.0000.0019.95165329.69%
2022/09/2200.00111.7011.50-1116-0.86%
2022/09/21111.4500.0011.7011160.86%
2022/08/1900.00310.4710.10-3121-2.47%
2022/08/0900.00112.7012.55-1107-0.93%
2022/08/0800.00212.7812.55-2107-1.86%
2022/08/0400.00812.3112.40-8109-7.34%
2022/08/01213.20213.0013.0001110.00%
2022/07/29113.3000.0013.1011110.90%
2022/07/281013.6300.0013.45101109.06%
2022/07/27314.1300.0014.1531092.75%
2022/05/0400.00315.0315.05-3139-2.15%
2022/04/2200.00515.2015.65-5121-4.11%
2022/04/21314.9800.0015.0031162.58%
2022/04/20514.6500.0015.3551134.42%
2022/01/0300.00315.9715.90-3121-2.47%
2021/12/1700.001016.4016.20-10111-8.99%
2021/12/0300.00216.2516.20-2105-1.90%
2021/12/01216.1000.0016.0521041.92%
2021/11/301216.1100.0016.101210411.51%
2021/11/26115.4500.0016.001841.18%
2021/06/1800.00116.1516.15-1475-0.21%
2021/05/17119.3000.0019.6015060.20%
2021/04/2300.00517.2517.15-5344-1.45%
2021/04/161518.0000.0018.20153324.51%
2021/04/15517.5500.0017.6053291.52%
2021/04/13819.3000.0018.2083222.48%
2021/02/2300.00117.9517.45-1193-0.52%
2021/02/22116.6000.0017.6011760.57%
2021/02/1700.00314.9815.00-3170-1.76%
2021/01/2000.00515.6015.80-5210-2.37%
2020/12/3100.00417.1517.35-4350-1.14%
2020/12/0400.00118.4518.35-1365-0.27%
2020/11/13519.8400.0019.5554131.21%
2020/10/2900.00718.7519.45-7497-1.41%
2020/10/28720.4000.0019.0075091.38%
2020/10/2200.00222.7521.20-2561-0.36%
2020/10/2100.00121.4521.75-1544-0.18%
2020/10/20119.75219.7519.80-1546-0.18%
2020/10/1600.00116.0016.40-1602-0.17%
2020/09/0400.00119.4519.40-11,809-0.06%
2020/08/2600.00121.2020.95-11,940-0.05%
2020/08/2500.00720.6020.30-71,954-0.36%
2020/08/24720.651020.8820.80-31,982-0.15%
2020/08/211021.15121.0521.1592,0470.44%
2020/08/20219.8300.0019.7022,1210.09%
2020/08/1300.00124.3523.50-12,317-0.04%
2020/08/12123.8000.0023.8012,3270.04%
2020/08/0700.00524.2024.20-52,307-0.22%
2020/08/06724.3900.0024.3072,3020.30%
2020/08/03125.55625.6526.40-52,273-0.22%
2020/07/31124.6500.0024.6512,2630.04%
2020/07/30325.2000.0025.2532,2720.13%
2020/07/29325.55624.6025.55-32,273-0.13%
2020/07/28623.431924.3923.40-132,265-0.57%
2020/07/27226.30124.6024.9012,2480.04%
2020/07/242227.9200.0027.00222,2360.98%
2020/07/22129.9000.0030.0012,2040.05%
2020/07/1700.00726.1526.15-72,068-0.34%
2020/07/16329.8700.0029.0532,0180.15%
2020/07/15529.90330.5030.8021,9830.10%
2020/07/1400.00230.5029.60-21,907-0.10%
2020/07/13231.0000.0031.5521,7930.11%
2020/07/1000.00428.6328.70-41,666-0.24%
2020/06/17525.50725.1125.35-21,350-0.15%
2020/06/15224.10923.4324.20-71,207-0.58%
2020/06/121121.2100.0022.00111,1240.98%
2020/06/11520.9000.0021.0051,0770.46%
2020/06/0800.00317.4318.00-3946-0.32%
2020/06/05317.2500.0017.3039450.32%
2020/05/28319.45517.6018.50-2978-0.20%
2020/05/22517.3000.0017.9059300.54%
2020/05/1300.00211.6012.15-2786-0.25%
2020/05/0800.00811.9611.80-8778-1.03%
2020/05/06812.9700.0012.6587611.05%
2020/05/04212.0500.0012.4027240.28%
2020/03/2600.0068.128.60-6667-0.90%
2020/03/16610.1300.0010.0066160.97%
2020/03/0500.00415.1014.35-4482-0.83%
2020/03/02413.9500.0014.6043971.01%
2020/02/2700.00213.3513.30-2359-0.56%
2020/01/0600.00110.6510.60-198-1.02%
2020/01/02110.8000.0010.851791.26%
2019/12/1700.00110.2010.05-165-1.53%
2019/09/11211.5300.0011.8021701.17%
2018/04/2500.00119.7519.80-1370-0.27%
2018/04/2000.00220.4320.20-2362-0.55%
2018/04/19220.4000.0020.9023580.56%
2018/04/12122.8000.0022.0012490.40%
2018/01/0300.00118.9018.75-1181-0.55%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音